| GILD |
Gilead Sciences, Inc. |
104.44B |
9.21% |
|
|
|
|
|
83.89 |
1.01% |
35.26% |
25.40% |
|---|
| REGN |
Regeneron Pharmaceuticals, Inc. |
123.47B |
8.68% |
|
|
|
|
|
1,138.81 |
-0.69% |
24.84% |
45.57% |
|---|
| AMGN |
Amgen Inc. |
178.89B |
7.88% |
|
|
|
|
|
332.92 |
0.04% |
34.71% |
32.51% |
|---|
| VRTX |
Vertex Pharmaceuticals Incorporated |
122.38B |
7.73% |
|
|
|
|
|
474.16 |
-1.48% |
26.04% |
54.41% |
|---|
| AZN |
AstraZeneca PLC |
243.64B |
4.00% |
|
|
|
|
|
78.58 |
0.06% |
23.22% |
42.24% |
|---|
| ALNY |
Alnylam Pharmaceuticals, Inc. |
35.07B |
3.17% |
|
|
|
|
|
273.15 |
-0.48% |
35.51% |
24.00% |
|---|
| BIIB |
Biogen Inc. |
28.78B |
2.97% |
|
|
|
|
|
197.59 |
-0.31% |
28.72% |
30.30% |
|---|
| MRNA |
Moderna, Inc. |
26.85B |
2.79% |
|
|
|
|
|
69.86 |
-2.96% |
77.97% |
75.53% |
|---|
| ILMN |
Illumina, Inc. |
20.86B |
2.01% |
|
|
|
|
|
130.97 |
0.58% |
40.75% |
14.46% |
|---|
| ARGX |
argenx SE |
31.64B |
1.76% |
|
|
|
|
|
529.06 |
1.31% |
27.65% |
5.72% |
|---|
| SNY |
Sanofi |
144.07B |
1.65% |
|
|
|
|
|
57.47 |
0.98% |
26.31% |
48.94% |
|---|
| BMRN |
BioMarin Pharmaceutical Inc. |
13.54B |
1.62% |
|
|
|
|
|
71.14 |
0.84% |
32.59% |
39.95% |
|---|
| UTHR |
United Therapeutics Corporation |
15.24B |
1.56% |
|
|
|
|
|
342.59 |
-0.70% |
25.90% |
45.79% |
|---|
| INCY |
Incyte Corporation |
12.55B |
1.40% |
|
|
|
|
|
65.17 |
-1.90% |
31.85% |
48.32% |
|---|
| VTRS |
Viatris Inc. |
14.20B |
1.36% |
|
|
|
|
|
11.90 |
0.68% |
32.19% |
43.98% |
|---|
| RPRX |
Royalty Pharma plc |
12.64B |
1.32% |
|
|
|
|
|
28.21 |
-0.11% |
25.38% |
41.87% |
|---|
| SRPT |
Sarepta Therapeutics, Inc. |
11.92B |
1.24% |
|
|
|
|
|
125.01 |
-0.54% |
40.95% |
2.86% |
|---|
| NBIX |
Neurocrine Biosciences, Inc. |
12.10B |
1.23% |
|
|
|
|
|
119.85 |
-2.01% |
30.04% |
14.33% |
|---|
| PCVX |
Vaxcyte, Inc. |
14.20B |
1.23% |
|
|
|
|
|
116.54 |
-0.18% |
33.32% |
1.16% |
|---|
| INSM |
Insmed Incorporated |
12.52B |
1.16% |
|
|
|
|
|
72.87 |
-0.53% |
63.49% |
14.67% |
|---|
| MEDP |
Medpace Holdings, Inc. |
11.20B |
1.06% |
|
|
|
|
|
361.29 |
1.87% |
38.98% |
42.83% |
|---|
| ROIV |
Roivant Sciences Ltd. |
8.87B |
0.92% |
|
|
|
|
|
12.00 |
-0.41% |
36.12% |
12.65% |
|---|
| BNTX |
BioNTech SE |
27.49B |
0.90% |
|
|
|
|
|
115.62 |
-7.29% |
48.88% |
64.66% |
|---|
| SMMT |
Summit Therapeutics Inc. |
17.79B |
0.88% |
|
|
|
|
|
24.56 |
-6.33% |
100.68% |
8.84% |
|---|
| BGNE |
BeiGene, Ltd. |
22.83B |
0.83% |
|
|
|
|
|
197.28 |
-0.12% |
33.41% |
14.07% |
|---|
| ITCI |
Intra-Cellular Therapies, Inc. |
7.89B |
0.79% |
|
|
|
|
|
74.70 |
-0.55% |
31.82% |
3.60% |
|---|
| HALO |
Halozyme Therapeutics, Inc. |
7.89B |
0.77% |
|
|
|
|
|
62.31 |
0.61% |
37.90% |
26.18% |
|---|
| EXEL |
Exelixis, Inc. |
7.65B |
0.74% |
|
|
|
|
|
26.82 |
-2.83% |
52.36% |
41.28% |
|---|
| ASND |
Ascendis Pharma A/S |
8.54B |
0.70% |
|
|
|
|
|
148.88 |
1.56% |
33.26% |
3.02% |
|---|
| RVMD |
Revolution Medicines, Inc. |
7.36B |
0.70% |
|
|
|
|
|
44.06 |
0.66% |
59.42% |
27.24% |
|---|
| IONS |
Ionis Pharmaceuticals, Inc. |
6.68B |
0.69% |
|
|
|
|
|
42.36 |
2.05% |
34.36% |
34.79% |
|---|
| JAZZ |
Jazz Pharmaceuticals plc |
6.77B |
0.68% |
|
|
|
|
|
109.57 |
-1.78% |
31.55% |
13.04% |
|---|
| CYTK |
Cytokinetics, Incorporated |
6.58B |
0.63% |
|
|
|
|
|
55.94 |
-0.39% |
85.15% |
19.59% |
|---|
| BBIO |
BridgeBio Pharma, Inc. |
4.88B |
0.58% |
|
|
|
|
|
25.96 |
-2.88% |
58.01% |
32.95% |
|---|
| BPMC |
Blueprint Medicines Corporation |
5.66B |
0.55% |
|
|
|
|
|
89.33 |
3.26% |
45.52% |
27.76% |
|---|
| KRYS |
Krystal Biotech, Inc. |
5.25B |
0.53% |
|
|
|
|
|
182.74 |
-3.45% |
42.54% |
30.56% |
|---|
| MDGL |
Madrigal Pharmaceuticals, Inc. |
5.06B |
0.52% |
|
|
|
|
|
233.16 |
-0.09% |
50.44% |
4.26% |
|---|
| NUVL |
Nuvalent, Inc. |
6.65B |
0.52% |
|
|
|
|
|
102.63 |
-2.02% |
37.00% |
-5.92% |
|---|
| APLS |
Apellis Pharmaceuticals, Inc. |
4.34B |
0.50% |
|
|
|
|
|
35.63 |
0.28% |
86.47% |
41.02% |
|---|
| IMVT |
Immunovant, Inc. |
4.23B |
0.50% |
|
|
|
|
|
28.90 |
-0.62% |
54.29% |
23.93% |
|---|
| RARE |
Ultragenyx Pharmaceutical Inc. |
5.32B |
0.46% |
|
|
|
|
|
57.70 |
-1.35% |
49.06% |
24.35% |
|---|
| ALKS |
Alkermes plc |
4.58B |
0.46% |
|
|
|
|
|
27.83 |
0.32% |
36.88% |
52.75% |
|---|
| AXSM |
Axsome Therapeutics, Inc. |
4.39B |
0.45% |
|
|
|
|
|
91.54 |
0.66% |
38.56% |
23.60% |
|---|
| CRNX |
Crinetics Pharmaceuticals, Inc. |
4.22B |
0.40% |
|
|
|
|
|
52.77 |
-0.42% |
49.08% |
45.07% |
|---|
| LEGN |
Legend Biotech Corporation |
9.14B |
0.40% |
|
|
|
|
|
49.91 |
-2.46% |
58.70% |
45.72% |
|---|
| RNA |
Avidity Biosciences, Inc. |
5.23B |
0.39% |
|
|
|
|
|
44.63 |
5.78% |
46.12% |
3.50% |
|---|
| ACLX |
Arcellx, Inc. |
4.33B |
0.39% |
|
|
|
|
|
80.55 |
3.28% |
49.77% |
35.22% |
|---|
| CRSP |
CRISPR Therapeutics AG |
4.22B |
0.38% |
|
|
|
|
|
49.59 |
-0.56% |
57.06% |
18.69% |
|---|
| ADMA |
ADMA Biologics, Inc. |
4.50B |
0.38% |
|
|
|
|
|
19.32 |
3.26% |
40.69% |
4.95% |
|---|
| DNLI |
Denali Therapeutics Inc. |
4.40B |
0.36% |
|
|
|
|
|
30.76 |
0.26% |
98.27% |
57.54% |
|---|
| FOLD |
Amicus Therapeutics, Inc. |
3.24B |
0.35% |
|
|
|
|
|
10.91 |
-2.59% |
50.56% |
21.26% |
|---|
| MRUS |
Merus N.V. |
3.37B |
0.34% |
|
|
|
|
|
49.42 |
-1.36% |
46.43% |
10.62% |
|---|
| DYN |
Dyne Therapeutics, Inc. |
3.45B |
0.33% |
|
|
|
|
|
34.34 |
-0.75% |
69.88% |
9.43% |
|---|
| RYTM |
Rhythm Pharmaceuticals, Inc. |
3.28B |
0.30% |
|
|
|
|
|
53.64 |
0.88% |
97.97% |
70.77% |
|---|
| GH |
Guardant Health, Inc. |
3.09B |
0.29% |
|
|
|
|
|
25.08 |
-0.04% |
88.83% |
49.60% |
|---|
| XENE |
Xenon Pharmaceuticals Inc. |
3.04B |
0.29% |
|
|
|
|
|
40.09 |
0.00% |
51.60% |
27.92% |
|---|
| SWTX |
SpringWorks Therapeutics, Inc. |
2.64B |
0.29% |
|
|
|
|
|
35.58 |
0.45% |
52.22% |
24.19% |
|---|
| IOVA |
Iovance Biotherapeutics, Inc. |
3.09B |
0.28% |
|
|
|
|
|
10.17 |
-2.40% |
75.87% |
8.95% |
|---|
| KYMR |
Kymera Therapeutics, Inc. |
2.96B |
0.28% |
|
|
|
|
|
46.44 |
-1.82% |
36.82% |
-4.06% |
|---|
| ARWR |
Arrowhead Pharmaceuticals, Inc. |
2.58B |
0.28% |
|
|
|
|
|
20.78 |
3.85% |
54.13% |
75.43% |
|---|
| IDYA |
IDEAYA Biosciences, Inc. |
2.94B |
0.28% |
|
|
|
|
|
34.75 |
-2.88% |
76.90% |
66.55% |
|---|
| ACAD |
ACADIA Pharmaceuticals Inc. |
2.71B |
0.27% |
|
|
|
|
|
16.33 |
0.43% |
32.02% |
0.01% |
|---|
| GERN |
Geron Corporation |
2.72B |
0.26% |
|
|
|
|
|
4.52 |
-0.66% |
44.34% |
-2.25% |
|---|
| AGIO |
Agios Pharmaceuticals, Inc. |
2.59B |
0.25% |
|
|
|
|
|
45.54 |
-0.33% |
65.65% |
75.33% |
|---|
| MYGN |
Myriad Genetics, Inc. |
2.59B |
0.25% |
|
|
|
|
|
28.47 |
-0.45% |
37.45% |
26.60% |
|---|
| PTGX |
Protagonist Therapeutics, Inc. |
2.64B |
0.25% |
|
|
|
|
|
44.77 |
-0.31% |
127.91% |
42.43% |
|---|
| PTCT |
PTC Therapeutics, Inc. |
2.73B |
0.24% |
|
|
|
|
|
35.48 |
1.17% |
52.62% |
9.88% |
|---|
| IBRX |
ImmunityBio, Inc. |
2.38B |
0.24% |
|
|
|
|
|
3.42 |
3.01% |
172.52% |
12.51% |
|---|
| AMPH |
Amphastar Pharmaceuticals, Inc. |
2.42B |
0.23% |
|
|
|
|
|
49.78 |
2.34% |
103.47% |
8.61% |
|---|
| VCEL |
Vericel Corporation |
2.27B |
0.22% |
|
|
|
|
|
46.35 |
4.58% |
42.47% |
38.80% |
|---|
| VCYT |
Veracyte, Inc. |
2.59B |
0.22% |
|
|
|
|
|
33.76 |
-1.63% |
164.89% |
50.63% |
|---|
| JANX |
Janux Therapeutics, Inc. |
2.52B |
0.22% |
|
|
|
|
|
48.32 |
-2.30% |
99.76% |
45.54% |
|---|
| TWST |
Twist Bioscience Corporation |
2.75B |
0.22% |
|
|
|
|
|
47.02 |
-1.36% |
66.57% |
78.50% |
|---|
| APGE |
Apogee Therapeutics, Inc. |
3.12B |
0.22% |
|
|
|
|
|
53.34 |
5.33% |
53.28% |
42.68% |
|---|
| VERA |
Vera Therapeutics, Inc. |
2.21B |
0.21% |
|
|
|
|
|
40.33 |
0.77% |
50.84% |
1.25% |
|---|
| HRMY |
Harmony Biosciences Holdings, Inc. |
2.18B |
0.20% |
|
|
|
|
|
38.34 |
-1.21% |
77.89% |
65.36% |
|---|
| MIRM |
Mirum Pharmaceuticals, Inc. |
1.81B |
0.20% |
|
|
|
|
|
37.90 |
-5.93% |
73.26% |
48.94% |
|---|
| BEAM |
Beam Therapeutics Inc. |
2.10B |
0.19% |
|
|
|
|
|
25.51 |
-0.27% |
55.45% |
36.81% |
|---|
| KROS |
Keros Therapeutics, Inc. |
2.09B |
0.19% |
|
|
|
|
|
55.71 |
1.22% |
49.13% |
11.53% |
|---|
| NTLA |
Intellia Therapeutics, Inc. |
2.29B |
0.19% |
|
|
|
|
|
22.52 |
-0.13% |
67.43% |
43.97% |
|---|
| SUPN |
Supernus Pharmaceuticals, Inc. |
1.75B |
0.19% |
|
|
|
|
|
31.84 |
0.38% |
41.42% |
23.49% |
|---|
| VRNA |
Verona Pharma plc |
2.45B |
0.19% |
|
|
|
|
|
29.23 |
0.14% |
70.24% |
7.35% |
|---|
| AKRO |
Akero Therapeutics, Inc. |
1.87B |
0.18% |
|
|
|
|
|
26.96 |
1.20% |
50.46% |
5.85% |
|---|
| NVCR |
NovoCure Limited |
1.91B |
0.18% |
|
|
|
|
|
17.61 |
-2.28% |
67.65% |
17.71% |
|---|
| GPCR |
Structure Therapeutics Inc. |
2.19B |
0.18% |
|
|
|
|
|
38.26 |
-0.47% |
79.62% |
20.90% |
|---|
| LGND |
Ligand Pharmaceuticals Incorporated |
1.89B |
0.18% |
|
|
|
|
|
103.68 |
-0.56% |
46.25% |
62.09% |
|---|
| FTRE |
Fortrea Holdings Inc. |
2.06B |
0.18% |
|
|
|
|
|
22.98 |
3.75% |
57.84% |
39.39% |
|---|
| RCKT |
Rocket Pharmaceuticals, Inc. |
1.90B |
0.17% |
|
|
|
|
|
20.84 |
-4.40% |
61.20% |
50.26% |
|---|
| ARVN |
Arvinas, Inc. |
1.71B |
0.17% |
|
|
|
|
|
24.97 |
-1.38% |
74.07% |
21.88% |
|---|
| BCRX |
BioCryst Pharmaceuticals, Inc. |
1.65B |
0.17% |
|
|
|
|
|
7.96 |
0.51% |
50.17% |
8.08% |
|---|
| EWTX |
Edgewise Therapeutics, Inc. |
1.79B |
0.17% |
|
|
|
|
|
19.07 |
5.50% |
206.23% |
70.73% |
|---|
| NVAX |
Novavax, Inc. |
2.01B |
0.17% |
|
|
|
|
|
12.56 |
-2.86% |
140.94% |
51.55% |
|---|
| SNDX |
Syndax Pharmaceuticals, Inc. |
1.53B |
0.16% |
|
|
|
|
|
18.00 |
-0.33% |
117.62% |
31.96% |
|---|
| MNKD |
MannKind Corporation |
1.83B |
0.16% |
|
|
|
|
|
6.66 |
1.52% |
121.35% |
14.58% |
|---|
| KURA |
Kura Oncology, Inc. |
1.55B |
0.15% |
|
|
|
|
|
20.26 |
0.50% |
105.03% |
28.51% |
|---|
| DVAX |
Dynavax Technologies Corporation |
1.47B |
0.15% |
|
|
|
|
|
11.21 |
-0.44% |
28.82% |
28.99% |
|---|
| AVDL |
Avadel Pharmaceuticals plc |
1.31B |
0.14% |
|
|
|
|
|
13.65 |
-1.30% |
99.99% |
80.96% |
|---|
| NRIX |
Nurix Therapeutics, Inc. |
1.59B |
0.14% |
|
|
|
|
|
24.74 |
-0.36% |
107.76% |
8.62% |
|---|
| RXRX |
Recursion Pharmaceuticals, Inc. |
1.90B |
0.14% |
|
|
|
|
|
6.91 |
2.22% |
74.88% |
8.58% |
|---|
| HROW |
Harrow Health, Inc. |
1.61B |
0.14% |
|
|
|
|
|
45.33 |
4.04% |
80.96% |
25.33% |
|---|